The role of cognitive and emotional risk factors in decision-making - Suicide Risk

niversitätsklinikum der RWTH Aachen0 sites60 target enrollmentSeptember 18, 2018

Overview

No summary available.

Registry

who.int

Start Date

September 18, 2018

End Date

TBD

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

niversitätsklinikum der RWTH Aachen

•General inclusion criteria:
•\- Subject is 18 to 60 years of age on the day of signing informed consent.
•\- Subject agrees to participate by providing written informed consent
•\- Subject is able to obtain full insight into the objectives of the clinical trial and is fully contractually capable as assessed by an independent psychiatrist.
•\- For patients: voluntary treatment in the Department for Psychiatry, Psychotherapy and Psychosomatics.
•Special inclusion criteria:
•\- Suicidal behavior (suicide ideas, realized or interrupted suicide attempts) within the last 6 months
•\- Subject meets ICD\-10 criteria for single depressive episode (F32\.x), bipolar depression (F31\.x), recurrent depression (F33\.x) or adjustment disorder with depressive reaction (F43\.2\).
•\- Absence of acute suicidality and stabile psychopathological state.
•\- Persistence of depressive symptoms (BDI \= 14\).

•\- Any comorbidity including following diagnostic categories: Organic, including symptomatic, mental disorders (F00\-F09\), Schizophrenia, schizotypal and delusional disorders (F20\-F29\), Mental retardation (F70\-F79\), Disorders of psychological development (F80\-89\).
•\- Subject has an unstable, severe medical disorder.
•\- Subject is hospitalized or treated coercively by order of the responsible local authorities.
•\- Subject (in the investigator's and \- if necessary \- an independent psychiatrist’s judgment) poses a serious suicidal or homicidal risk at the screening visit
•\- Subject has a clinically significant abnormality in the neurological assessments at screen or base
•\- subject is in a dependent position toward the investigators.